Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy
Open Access
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 12 (3) , 773-780
- https://doi.org/10.1016/0735-1097(88)90320-8
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.Circulation, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Effect of propranolol in postinfarction patients with mechanical or electrical complications.Circulation, 1984
- Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patientLife Sciences, 1982
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blockerAmerican Heart Journal, 1979
- Propranolol in the Treatment of Acute Myocardial InfarctionCirculation, 1974
- Adverse Reactions to ??-Adrenergic Receptor Blocking DrugsDrugs, 1974